Clinical trial
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals'…
NCT00322335 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00322335 |
|---|---|
| Title | Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC |
| Official title | Phase III, Open, Multicenter Study to Assess the Long-Term Persistence of a Booster Dose of GSK Biologicals' Hib-MenC Compared to a Booster Dose of Infanrix™ Hexa When Given to 14 Month-old Subjects Primed in Study DTPa-HBV-IPV-097 & Boosted in Study Hib-MenC-TT-010 BST: DTPa-HBV-IPV-097 |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Haemophilus Influenzae Type b, Neisseria Meningitidis |
| Intervention type | Biological |
| Interventions | Haemophilus influenzae type b- and meningococcal (vaccine), Infanrix™ penta, Infanrix™ hexa, Engerix-B, NeisVac-C™, Infanrix™ IPV/HIB, Meningitec™ |
| Enrollment | 230 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Sep 1, 2010 |
| First posted | May 5, 2006 |
| Last update posted | Oct 20, 2016 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: